Fragments of DNA that are derived from dead tumour cells and shed into a patient's blood have been utilized as biomarkers for the diagnosis and prognosis of liver cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Xu, R.-h. et al. Nat. Mater. 16, 1155–1161 (2017).
Wan, J. C. M. et al. Nat. Rev. Cancer 17, 223–238 (2017).
Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Nat. Rev. Clin. Oncol. 10, 472–884 (2013).
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra24 (2014).
Tanić, M. & Beck, S. Curr. Opin. Genet. Dev. 42, 48–55 (2017).
Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Science 357, eaal2380 (2017).
Clinical Cancer Genome Task Team of the Global Alliance for Genomics and Health N. Engl. J. Med. 376, 2006–2009 (2017).
Wrzeszczynski, K. O. et al. Neurol. Genet. 3, e164 (2017).
Ahmad, A. S., Ormiston-Smith, N. & Sasieni, P. D. Br. J. Cancer. 112, 943–947 (2015).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanić, M., Beck, S. Treasure trove for cancer medicine. Nature Mater 16, 1056–1057 (2017). https://doi.org/10.1038/nmat5019
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmat5019
